Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'

Documenti analoghi

• Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
  di: Papakostas, T D, et al.
  Pubblicazione: (2016)
• Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab'
  di: Papakostas, T D, et al.
  Pubblicazione: (2016)
• Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
  di: Yuan, Alex, et al.
  Pubblicazione: (2014)
• Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion
  di: Ozgonul, Cem, et al.
  Pubblicazione: (2018)
• Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
  di: Wang, Jia-Kang, et al.
  Pubblicazione: (2016)